Radiotherapy for Nonmalignant Eye Diseases: Graves' Ophthalmopathy - Pseudotumor Orbitae

Area of Science:

• Ophthalmology
• Radiation Oncology
• Endocrinology

Background:

• Graves' ophthalmopathy (GO) causes painful eye symptoms due to soft tissue swelling.
• Orbital radiotherapy (RT) is a recognized treatment for moderate-to-severe GO.
• RT can reduce inflammation, improve eye movement, and decrease reliance on steroids.

Purpose of the Study:

• To review the efficacy and safety of orbital radiotherapy for Graves' ophthalmopathy.
• To discuss RT dose fractionation and target volume considerations.
• To highlight RT's role in managing different phases of GO.

Main Methods:

• Review of existing literature on orbital radiotherapy for GO.
• Discussion of treatment techniques including lateral opposing fields and intensity-modulated radiotherapy (IMRT).
• Analysis of dose concepts adapted to disease phases and fractionation schedules.

Main Results:

• Orbital RT effectively reduces GO symptoms like swelling and pain.
• Treatment is generally well-tolerated, with common side effects including temporary dryness and conjunctivitis.
• Long-term risks are rare, including cataracts and a minimal theoretical risk of radiation-induced cancer.

Conclusions:

• Orbital radiotherapy is a valuable treatment for Graves' ophthalmopathy, particularly when combined with steroids.
• Dosing and fractionation should be tailored to the specific phase of the disease.
• RT offers a non-immediate but significant improvement in symptoms and ocular function.